{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:47:36Z","timestamp":1793274456129,"version":"4.5.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"DOI":"10.1038\/s41388-026-03980-w","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:07:25Z","timestamp":1790154445000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["DDR1 sustains ferroptosis resistance in pancreatic ductal adenocarcinoma via SLC40A1-mediated iron homeostasis"],"prefix":"10.1038","author":[{"given":"Chao","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4430-9378","authenticated-orcid":false,"given":"Sheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-An","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai Xuan","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganggang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazhou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taochen","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7162-7420","authenticated-orcid":false,"given":"Bing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianzhi","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4696-8098","authenticated-orcid":false,"given":"Wenquan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3973-5405","authenticated-orcid":false,"given":"Jingjing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5820-6843","authenticated-orcid":false,"given":"Wenhui","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0403-6580","authenticated-orcid":false,"given":"Liang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"3980_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"3980_CR2","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","volume":"405","author":"TF Stoop","year":"2025","unstructured":"Stoop TF, Javed AA, Oba A, Koerkamp BG, Seufferlein T, Wilmink JW, et al. Pancreatic cancer. Lancet. 2025;405:1182\u2013202.","journal-title":"Lancet"},{"key":"3980_CR3","doi-asserted-by":"publisher","first-page":"e214708","DOI":"10.1001\/jamanetworkopen.2021.4708","volume":"4","author":"L Rahib","year":"2021","unstructured":"Rahib L, Wehner MR, Matrisian LM, Nead KT. Estimated projection of US cancer incidence and death to 2040. JAMA Netw Open. 2021;4:e214708.","journal-title":"JAMA Netw Open"},{"key":"3980_CR4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1001\/jama.297.3.267","volume":"297","author":"H Oettle","year":"2007","unstructured":"Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA. 2007;297:267\u201377.","journal-title":"JAMA"},{"key":"3980_CR5","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.2174\/0929867324666170510150124","volume":"24","author":"H Mangge","year":"2017","unstructured":"Mangge H, Niedrist T, Renner W, Lyer S, Alexiou C, Haybaeck J. New diagnostic and therapeutic aspects of pancreatic ductal adenocarcinoma. Curr Med Chem. 2017;24:3012\u201324.","journal-title":"Curr Med Chem"},{"key":"3980_CR6","doi-asserted-by":"publisher","DOI":"10.1177\/1756284819878660","volume":"12","author":"N Williet","year":"2019","unstructured":"Williet N, Saint A, Pointet AL, Tougeron D, Pernot S, Pozet A, et al. Folfirinox versus gemcitabine\/nab-paclitaxel as first-line therapy in patients with metastatic pancreatic cancer: a comparative propensity score study. Ther Adv Gastroenterol. 2019;12:1756284819878660.","journal-title":"Ther Adv Gastroenterol"},{"key":"3980_CR7","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","volume":"369","author":"DD Von Hoff","year":"2013","unstructured":"Von Hoff DD, Ervin T, Arena FP, Chiorean EG, Infante J, Moore M, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med. 2013;369:1691\u2013703.","journal-title":"N Engl J Med"},{"key":"3980_CR8","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-024-01948-4","volume":"9","author":"J Cui","year":"2024","unstructured":"Cui J, Qin S, Zhou Y, Zhang S, Sun X, Zhang M, et al. Irinotecan hydrochloride liposome HR070803 in combination with 5-fluorouracil and leucovorin in locally advanced or metastatic pancreatic ductal adenocarcinoma following prior gemcitabine-based therapy (PAN-HEROIC-1): a phase 3 trial. Signal Transduct Target Ther. 2024;9:248.","journal-title":"Signal Transduct Target Ther"},{"key":"3980_CR9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41392-024-02031-8","volume":"9","author":"K Cheng","year":"2024","unstructured":"Cheng K, Li X, Lv W, Zhao G, Zhou R, Chang C, et al. Spatial interactions of immune cells as potential predictors to efficacy of toripalimab plus chemotherapy in locally advanced or metastatic pancreatic ductal adenocarcinoma: a phase Ib\/II trial. Signal Transduct Target Ther. 2024;9:321.","journal-title":"Signal Transduct Target Ther"},{"key":"3980_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2019.04.003","volume":"1866","author":"YC Yeh","year":"2019","unstructured":"Yeh YC, Lin HH, Tang MJ. Dichotomy of the function of DDR1 in cells and disease progression. Biochim Biophys Acta Mol Cell Res. 2019;1866:118473.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"3980_CR11","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.tcb.2023.08.003","volume":"34","author":"H Su","year":"2024","unstructured":"Su H, Karin M. Multifaceted collagen-DDR1 signaling in cancer. Trends Cell Biol. 2024;34:406\u201315.","journal-title":"Trends Cell Biol"},{"key":"3980_CR12","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1007\/s12672-025-02107-z","volume":"16","author":"Y Luo","year":"2025","unstructured":"Luo Y, Liu T, Pei J, Xu S, Liu J, Yu J. Emerging strategies and translational advancements of DDR1 in oncology. Discov Oncol. 2025;16:428.","journal-title":"Discov Oncol"},{"key":"3980_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0782-4","volume":"17","author":"Z Du","year":"2018","unstructured":"Du Z, Lovly CM. Mechanisms of receptor tyrosine kinase activation in cancer. Mol Cancer. 2018;17:58.","journal-title":"Mol Cancer"},{"key":"3980_CR14","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.cell.2010.06.011","volume":"141","author":"MA Lemmon","year":"2010","unstructured":"Lemmon MA, Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 2010;141:1117\u201334.","journal-title":"Cell"},{"key":"3980_CR15","doi-asserted-by":"publisher","first-page":"e1005249","DOI":"10.1371\/journal.pgen.1005249","volume":"11","author":"Q Xiao","year":"2015","unstructured":"Xiao Q, Jiang Y, Liu Q, Yue J, Liu C, Zhao X, et al. Minor Type IV collagen alpha5 chain promotes cancer progression through discoidin domain receptor-1. PLoS Genet. 2015;11:e1005249.","journal-title":"PLoS Genet"},{"key":"3980_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-019-1071-5","volume":"20","author":"L Ye","year":"2019","unstructured":"Ye L, Pu C, Tang J, Wang Y, Wang C, Qiu Z, et al. Transmembrane-4 L-six family member-1 (TM4SF1) promotes non-small cell lung cancer proliferation, invasion and chemo-resistance through regulating the DDR1\/Akt\/ERK-mTOR axis. Respir Res. 2019;20:106.","journal-title":"Respir Res"},{"key":"3980_CR17","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1038\/s41388-022-02212-1","volume":"41","author":"X Zhang","year":"2022","unstructured":"Zhang X, Hu Y, Pan Y, Xiong Y, Zhang Y, Han M, et al. DDR1 promotes hepatocellular carcinoma metastasis through recruiting PSD4 to ARF6. Oncogene. 2022;41:1821\u201334.","journal-title":"Oncogene"},{"key":"3980_CR18","doi-asserted-by":"publisher","first-page":"770","DOI":"10.21037\/tlcr-23-88","volume":"12","author":"F Ming","year":"2023","unstructured":"Ming F, Li B, Yi S, Pi G. Circ_0087378 intensifies the malignant behavior of non-small cell lung cancer cells in vitro by facilitating DDR1 via sponging miR-199a-5p. Transl Lung Cancer Res. 2023;12:770\u201385.","journal-title":"Transl Lung Cancer Res"},{"key":"3980_CR19","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1093\/emboj\/cdg129","volume":"22","author":"PP Ongusaha","year":"2003","unstructured":"Ongusaha PP, Kim JI, Fang L, Wong TW, Yancopoulos GD, Aaronson SA, et al. p53 induction and activation of DDR1 kinase counteract p53-mediated apoptosis and influence p53 regulation through a positive feedback loop. EMBO J. 2003;22:1289\u2013301.","journal-title":"EMBO J"},{"key":"3980_CR20","doi-asserted-by":"publisher","first-page":"19539","DOI":"10.1002\/jcp.28552","volume":"234","author":"R Azizi","year":"2019","unstructured":"Azizi R, Salemi Z, Fallahian F, Aghaei M. Inhibition of didscoidin domain receptor 1 reduces epithelial-mesenchymal transition and induce cell-cycle arrest and apoptosis in prostate cancer cell lines. J Cell Physiol. 2019;234:19539\u201352.","journal-title":"J Cell Physiol"},{"key":"3980_CR21","doi-asserted-by":"crossref","unstructured":"Liu J, Chiang HC, Xiong W, Laurent V, Griffiths SC, D\u00fclfer J, et al. A highly selective humanized DDR1 mAb reverses immune exclusion by disrupting collagen fiber alignment in breast cancer. J Immunother Cancer. 2023;11:e006720.","DOI":"10.1136\/jitc-2023-006720"},{"key":"3980_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107500","volume":"149","author":"X Wang","year":"2024","unstructured":"Wang X, Lu Y, Chen S, Zhu Z, Fu Y, Zhang J, et al. Discovery of a prominent dual-target DDR1\/EGFR inhibitor aimed DDR1\/EGFR-positive NSCLC. Bioorg Chem. 2024;149:107500.","journal-title":"Bioorg Chem"},{"key":"3980_CR23","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1158\/0008-5472.CAN-22-1159","volume":"83","author":"CK Wang","year":"2023","unstructured":"Wang CK, Chen TJ, Tan GYT, Chang FP, Sridharan S, Yu CA, et al. MEX3A Mediates p53 degradation to suppress ferroptosis and facilitate ovarian cancer tumorigenesis. Cancer Res. 2023;83:251\u201363.","journal-title":"Cancer Res"},{"key":"3980_CR24","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jhep.2023.03.016","volume":"79","author":"F He","year":"2023","unstructured":"He F, Zhang P, Liu J, Wang R, Kaufman RJ, Yaden BC, et al. ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis. J Hepatol. 2023;79:362\u201377.","journal-title":"J Hepatol"},{"key":"3980_CR25","doi-asserted-by":"crossref","unstructured":"Jiang Z, Lim SO, Yan M, Hsu JL, Yao J, Wei Y, et al. TYRO3 induces anti-PD-1\/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis. J Clin investig. 2021;131:139434.","DOI":"10.1172\/JCI139434"},{"key":"3980_CR26","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol cell Biol. 2021;22:266\u201382.","journal-title":"Nat Rev Mol cell Biol"},{"key":"3980_CR27","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31:107\u201325.","journal-title":"Cell Res"},{"key":"3980_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01530-y","volume":"21","author":"C Zhang","year":"2022","unstructured":"Zhang C, Liu X, Jin S, Chen Y, Guo R. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol cancer. 2022;21:47.","journal-title":"Mol cancer"},{"key":"3980_CR29","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s43018-023-00715-8","volume":"5","author":"H Zheng","year":"2024","unstructured":"Zheng H, Liu J, Cheng Q, Zhang Q, Zhang Y, Jiang L, et al. Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance. Nat cancer. 2024;5:572\u201389.","journal-title":"Nat cancer"},{"key":"3980_CR30","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s43018-022-00426-6","volume":"3","author":"M Yuan","year":"2022","unstructured":"Yuan M, Tu B, Li H, Pang H, Zhang N, Fan M, et al. Cancer-associated fibroblasts employ NUFIP1-dependent autophagy to secrete nucleosides and support pancreatic tumor growth. Nat Cancer. 2022;3:945\u201360.","journal-title":"Nat Cancer"},{"key":"3980_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2018.16","volume":"4","author":"P Brissot","year":"2018","unstructured":"Brissot P, Pietrangelo A, Adams PC, de Graaff B, McLaren CE, Lor\u00e9al O. Haemochromatosis. Nat Rev Dis Prim. 2018;4:18016.","journal-title":"Nat Rev Dis Prim"},{"key":"3980_CR32","doi-asserted-by":"publisher","first-page":"23208","DOI":"10.1074\/jbc.M116.740605","volume":"291","author":"H Huang","year":"2016","unstructured":"Huang H, Svoboda RA, Lazenby AJ, Saowapa J, Chaika N, Ding K, et al. Up-regulation of N-cadherin by collagen I-activated discoidin domain receptor 1 in pancreatic cancer requires the adaptor molecule Shc1. J Biol Chem. 2016;291:23208\u201323.","journal-title":"J Biol Chem"},{"key":"3980_CR33","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/nsmb.2557","volume":"20","author":"KM Suen","year":"2013","unstructured":"Suen KM, Lin CC, George R, Melo FA, Biggs ER, Ahmed Z, et al. Interaction with Shc prevents aberrant Erk activation in the absence of extracellular stimuli. Nat Struct Mol Biol. 2013;20:620\u20137.","journal-title":"Nat Struct Mol Biol"},{"key":"3980_CR34","doi-asserted-by":"crossref","unstructured":"Xie Y, Zhang X, Xu P, Zhao N, Zhao Y, Li Y, et al. Aberrant oligodendroglial LDL receptor orchestrates demyelination in chronic cerebral ischemia. J Clin Investig. 2021;131:e128114.","DOI":"10.1172\/JCI128114"},{"key":"3980_CR35","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.molcel.2006.01.009","volume":"21","author":"B Benassi","year":"2006","unstructured":"Benassi B, Fanciulli M, Fiorentino F, Porrello A, Chiorino G, Loda M, et al. c-Myc phosphorylation is required for cellular response to oxidative stress. Mol Cell. 2006;21:509\u201319.","journal-title":"Mol Cell"},{"key":"3980_CR36","doi-asserted-by":"crossref","unstructured":"Jing N, Zhang K, Chen X, Liu K, Wang J, Xiao L, et al. ADORA2A-driven proline synthesis triggers epigenetic reprogramming in neuroendocrine prostate and lung cancers. J Clin Investig. 2023;133:e168670.","DOI":"10.1172\/JCI168670"},{"key":"3980_CR37","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1101\/gad.836800","volume":"14","author":"R Sears","year":"2000","unstructured":"Sears R, Nuckolls F, Haura E, Taya Y, Tamai K, Nevins JR. Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability. Genes Dev. 2000;14:2501\u201314.","journal-title":"Genes Dev"},{"key":"3980_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02367-2","volume":"11","author":"G-Y Lai","year":"2025","unstructured":"Lai G-Y, Lee Y-C, Weng H-J, Lai K-H, Hsiang M-C, Hsu K-Y, et al. Discoidin domain receptor inhibitor DDR1-IN-1 induces autophagy and necroptotic cell death in malignant peripheral nerve sheath tumor. Cell Death Discov. 2025;11:83.","journal-title":"Cell Death Discov"},{"key":"3980_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2026.102683","volume":"7","author":"Y Pan","year":"2026","unstructured":"Pan Y, Zhao L, Liu J, Mao M, Tian A-L, Le Naour J, et al. Inhibition of MAPK p38\u03b1 overcomes the cancer immunosurveillance defect caused by FPR1 loss-of-function mutation. Cell Rep Med. 2026;7:102683.","journal-title":"Cell Rep Med"},{"key":"3980_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/wsbm.1644","volume":"16","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Zou L, Li X, Guo L, Hu B, Ye H, et al. SLC40A1 in iron metabolism, ferroptosis, and disease: a review. WIREs mechanisms Dis. 2024;16:e1644.","journal-title":"WIREs mechanisms Dis"},{"key":"3980_CR41","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.freeradbiomed.2018.12.011","volume":"131","author":"J Du","year":"2019","unstructured":"Du J, Wang T, Li Y, Zhou Y, Wang X, Yu X, et al. DHA inhibits proliferation and induces ferroptosis of leukemia cells through autophagy dependent degradation of ferritin. Free Radic Biol Med. 2019;131:356\u201369.","journal-title":"Free Radic Biol Med"},{"key":"3980_CR42","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.canlet.2016.07.033","volume":"381","author":"R Lin","year":"2016","unstructured":"Lin R, Zhang Z, Chen L, Zhou Y, Zou P, Feng C, et al. Dihydroartemisinin (DHA) induces ferroptosis and causes cell cycle arrest in head and neck carcinoma cells. Cancer Lett. 2016;381:165\u201375.","journal-title":"Cancer Lett"},{"key":"3980_CR43","doi-asserted-by":"publisher","first-page":"e0182921","DOI":"10.1371\/journal.pone.0182921","volume":"12","author":"S Ma","year":"2017","unstructured":"Ma S, Dielschneider RF, Henson ES, Xiao W, Choquette TR, Blankstein AR, et al. Ferroptosis and autophagy induced cell death occur independently after siramesine and lapatinib treatment in breast cancer cells. PLoS ONE. 2017;12:e0182921.","journal-title":"PLoS ONE"},{"key":"3980_CR44","doi-asserted-by":"publisher","first-page":"e2307","DOI":"10.1038\/cddis.2016.208","volume":"7","author":"S Ma","year":"2016","unstructured":"Ma S, Henson ES, Chen Y, Gibson SB. Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells. Cell Death Dis. 2016;7:e2307.","journal-title":"Cell Death Dis"},{"key":"3980_CR45","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.freeradbiomed.2017.04.363","volume":"111","author":"M Xiao","year":"2017","unstructured":"Xiao M, Zhong H, Xia L, Tao Y, Yin H. Pathophysiology of mitochondrial lipid oxidation: Role of 4-hydroxynonenal (4-HNE) and other bioactive lipids in mitochondria. Free Radic Biol Med. 2017;111:316\u201327.","journal-title":"Free Radic Biol Med"},{"key":"3980_CR46","doi-asserted-by":"crossref","unstructured":"Lee J, Hyun DH. The interplay between intracellular iron homeostasis and neuroinflammation in neurodegenerative diseases. Antioxidants. 2023;12:918.","DOI":"10.3390\/antiox12040918"},{"key":"3980_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2019.04.004","volume":"1866","author":"S Moll","year":"2019","unstructured":"Moll S, Desmouli\u00e8re A, Moeller MJ, Pache JC, Badi L, Arcadu F, et al. DDR1 role in fibrosis and its pharmacological targeting. Biochim Biophys Acta Mol Cell Res. 2019;1866:118474.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"3980_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2024.103975","volume":"29","author":"D Wu","year":"2024","unstructured":"Wu D, Ding Z, Lu T, Chen Y, Zhang F, Lu S. DDR1-targeted therapies: current limitations and future potential. Drug Discov Today. 2024;29:103975.","journal-title":"Drug Discov Today"},{"key":"3980_CR49","doi-asserted-by":"crossref","unstructured":"Deng J, Kang Y, Cheng CC, Li X, Dai B, Katz MH, et al. DDR1-induced neutrophil extracellular traps drive pancreatic cancer metastasis. JCI insight. 2021;6:e146133.","DOI":"10.1172\/jci.insight.146133"},{"key":"3980_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101079","volume":"74","author":"W Huang","year":"2024","unstructured":"Huang W, Hu X, He X, Pan D, Huang Z, Gu Z, et al. TRIM29 facilitates gemcitabine resistance via MEK\/ERK pathway and is modulated by circRPS29\/miR-770-5p axis in PDAC. Drug Resist Updat. 2024;74:101079.","journal-title":"Drug Resist Updat"},{"key":"3980_CR51","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/s41586-022-05169-z","volume":"610","author":"H Su","year":"2022","unstructured":"Su H, Yang F, Fu R, Trinh B, Sun N, Liu J, et al. Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome. Nature. 2022;610:366\u201372.","journal-title":"Nature"},{"key":"3980_CR52","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/s41419-023-06344-4","volume":"14","author":"H Xu","year":"2023","unstructured":"Xu H, Tan M, Hou GQ, Sang YZ, Lin L, Gan XC, et al. Blockade of DDR1\/PYK2\/ERK signaling suggesting SH2 superbinder as a novel autophagy inhibitor for pancreatic cancer. Cell Death Dis. 2023;14:811.","journal-title":"Cell Death Dis"},{"key":"3980_CR53","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1182\/blood.2020008986","volume":"138","author":"L Jiang","year":"2021","unstructured":"Jiang L, Wang J, Wang K, Wang H, Wu Q, Yang C, et al. RNF217 regulates iron homeostasis through its E3 ubiquitin ligase activity by modulating ferroportin degradation. Blood. 2021;138:689\u2013705.","journal-title":"Blood"},{"key":"3980_CR54","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.390","volume":"11","author":"Z Tang","year":"2021","unstructured":"Tang Z, Jiang W, Mao M, Zhao J, Chen J, Cheng N. Deubiquitinase USP35 modulates ferroptosis in lung cancer via targeting ferroportin. Clin Transl Med. 2021;11:e390.","journal-title":"Clin Transl Med"},{"key":"3980_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25632-1","volume":"12","author":"J Gao","year":"2021","unstructured":"Gao J, Luo T, Wang J. Gene interfered-ferroptosis therapy for cancers. Nat Commun. 2021;12:5311.","journal-title":"Nat Commun"},{"key":"3980_CR56","doi-asserted-by":"crossref","unstructured":"Jiang H, Muir RK, Gonciarz RL, Olshen AB, Yeh I, Hann BC, et al. Ferrous iron-activatable drug conjugate achieves potent MAPK blockade in KRAS-driven tumors. J Exp Med. 2022;219:e20210739.","DOI":"10.1084\/jem.20210739"},{"key":"3980_CR57","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2174\/0929867328666210810115812","volume":"29","author":"E Ozkan","year":"2022","unstructured":"Ozkan E, Bakar-Ates F. Ferroptosis: a trusted ally in combating drug resistance in cancer. Curr Med Chem. 2022;29:41\u201355.","journal-title":"Curr Med Chem"},{"key":"3980_CR58","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.freeradbiomed.2021.03.024","volume":"168","author":"S Bader","year":"2021","unstructured":"Bader S, Wilmers J, Pelzer M, Jendrossek V, Rudner J. Activation of anti-oxidant Keap1\/Nrf2 pathway modulates efficacy of dihydroartemisinin-based monotherapy and combinatory therapy with ionizing radiation. Free Radic Biol Med. 2021;168:44\u201354.","journal-title":"Free Radic Biol Med"},{"key":"3980_CR59","doi-asserted-by":"publisher","first-page":"e0120426","DOI":"10.1371\/journal.pone.0120426","volume":"10","author":"YJ Mi","year":"2015","unstructured":"Mi YJ, Geng GJ, Zou ZZ, Gao J, Luo XY, Liu Y, et al. Dihydroartemisinin inhibits glucose uptake and cooperates with glycolysis inhibitor to induce apoptosis in non-small cell lung carcinoma cells. PLoS ONE. 2015;10:e0120426.","journal-title":"PLoS ONE"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03980-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03980-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03980-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:08:41Z","timestamp":1793272121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03980-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":59,"alternative-id":["3980"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03980-w","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: For this article, the plain language summary was mistakenly omitted. The publisher would like to apologize for this omission.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. The study involving human participants was approved by the Ethics Committee of Zhongshan Hospital, Fudan University (approval number: b2024-152). Written informed consent was obtained from all participants. All animal experiments were approved by the Animal Ethics Committee of Zhongshan Hospital, Fudan University (approval number: 2023-271) and were conducted in compliance with the institutional and national guidelines for the care and use of laboratory animals.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}